The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

Authors

Keywords

Journal

Volume 200, Issue -, Pages 83-89

Publisher

Elsevier BV

Online

2018-02-08

DOI

10.1016/j.ahj.2018.01.012

Contact the author

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now